IP Strategy

Understanding how IP assets can best be created, protected and utilized to produce a competitive advantage is a key aspect of our IP Strategy offering. Applying keen insight gained from our proven legal and technical expertise, we excel in the area of due diligence, routinely uncovering issues in chain of title, encumbrances/obligations or enforcement/prosecution deficiencies often left undetected by other firms.

We are also widely recognized for providing thoughtful, well-founded and balanced legal opinions—maintaining strict objectivity, preserving the attorney-client and work product privileges, and avoiding bias or conjecture. We believe that such “balanced” legal opinions provide reasoned support for our clients should their actions be challenged in the future.

Explore related practice areas:

Knobbe Martens partners Sabing Lee and Kregg Koch authored “Medical device innovations and IP: A strategy is everything,” published in Life Sciences IP Review. In the piece, the authors discuss the...
The Pharma Letter has published an article from partner Jane Dai, Ph.D. on considerations for biotech and pharma firms when making use of intellectual property from federally-funded programs. The...
IRVINE, CALIF., July 22, 2022 – Knobbe Martens is pleased to share that the firm and its partners were shortlisted in six categories for the 2022 Euromoney Legal Media Group (LMG) “LMG Life Sciences...